Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
AgroSpheres and BASF Announce Major Strategic Partnership AgroSpheres and BASF Announce Major Strategic Partnership
RIVANNA initiates multi-site first-in-human study for Accuro XV musculoskeletal imaging system RIVANNA initiates multi-site first-in-human study for Accuro XV musculoskeletal imaging system
Rivus Pharmaceuticals Announces New Clinical Data from Phase 2a HuMAIN Trial Demonstrating Significant Weight Loss with HU6 in Patients with Obesity-Related Heart Failure Rivus Pharmaceuticals Logo (PRNewsfoto/Rivus Pharmaceuticals) Rivus Pharmaceuticals Announces New Clinical Data from Phase 2a HuMAIN Trial Demonstrating Significant Weight Loss with HU6 in Patients with Obesity-Related Heart Failure Rivus Pharmaceuticals Logo (PRNewsfoto/Rivus Pharmaceuticals)
AgroSpheres Secures $37M Series B Funding – Pushes for Growth AgroSpheres Secures $37M Series B Funding – Pushes for Growth
Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease
RIVANNA secures patent for groundbreaking ultrasound-guided needle insertion system RIVANNA secures patent for groundbreaking ultrasound-guided needle insertion system
Caretaker Medical Partners with Red One Medical to Bring Mobile ICU-Level Monitoring to Military Units and Veterans Caretaker Medical Partners with Red One Medical to Bring Mobile ICU-Level Monitoring to Military Units and Veterans
Sugar replacement: Bonumose secures preliminary victory over ‘arbitrary and capricious’ FDA on tagatose labeling Sugar replacement: Bonumose secures preliminary victory over ‘arbitrary and capricious’ FDA on tagatose labeling
Rivus succeeds in obesity-related heart failure, posting phase 2 win for muscle-sparing molecule Rivus succeeds in obesity-related heart failure, posting phase 2 win for muscle-sparing molecule
